Vericel Corporation - Common Stock (VCEL)
58.54
-0.71 (-1.20%)
Vericel Corporation is a biotechnology company that focuses on developing and commercializing innovative, cell-based products for a variety of medical needs
Specializing in regenerative medicine, Vericel primarily addresses the treatment of diseases and conditions affecting the skin and cartilage. Their flagship products are designed to enhance healing and improve patient outcomes, particularly in areas such as sports medicine and burn care. Through its commitment to research and development, Vericel aims to transform the treatment landscape for patients with complex medical needs.
Frequently Asked Questions
Is Vericel Corporation - Common Stock publicly traded?
Yes, Vericel Corporation - Common Stock is publicly traded.
What exchange does Vericel Corporation - Common Stock trade on?
Vericel Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vericel Corporation - Common Stock?
The ticker symbol for Vericel Corporation - Common Stock is VCEL on the Nasdaq Stock Market
What is the current price of Vericel Corporation - Common Stock?
The current price of Vericel Corporation - Common Stock is 58.54
When was Vericel Corporation - Common Stock last traded?
The last trade of Vericel Corporation - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Vericel Corporation - Common Stock?
The market capitalization of Vericel Corporation - Common Stock is 2.73B
How many shares of Vericel Corporation - Common Stock are outstanding?
Vericel Corporation - Common Stock has 46.63M shares outstanding.